Skip to main content

Table 1 Patient Characteristics

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

  CT BioCT
No. % No. %
No. patients 89   87  
Sex     
   Male 57 64.0 48 55.2
   Female 32 36.0 39 44.8
Age     
   Median 59   56  
   Range 26–76   25–77  
Performance status (ECOG)     
   0 60 67.4 59 67.8
   1 23 25.8 24 27.6
   2 6 6.7 4 4.6
Site of primary melanoma     
   Head and neck 16 18.0 16 18.4
   Body 35 39.3 36 41.4
   Arms 34 38.2 34 39.1
   Not referred 4 4.5 1 1.1
Sites of disease     
   Liver +/- others 30 33.7 32 36.8
   Viscera +/- others 29 32.6 31 35.6
   Bone + soft tissue and lymph nodes 4 4.5 2 2.3
   Soft tissue and lymph nodes 26 29.2 22 25.3